Development of a Non-Melanoma Skin Cancer Detection Model

被引:5
作者
van der Geer, Simone [1 ,2 ]
Kleingeld, P. Ad M. [3 ]
Snijders, Chris C. P. [3 ]
Rinkens, Frank J. C. H. [3 ]
Jansen, Geert A. E. [3 ]
Neumann, H. A. Martino [4 ]
Krekels, Gertruud A. M. [1 ,2 ]
机构
[1] MohsA Skin Canc Clin, NL-5803 AZ Venray, Netherlands
[2] MohsA Skin Canc Clin, Eindhoven, Netherlands
[3] Eindhoven Univ Technol, Dept Ind Engn & Innovat Sci, NL-5600 MB Eindhoven, Netherlands
[4] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
关键词
Skin cancer; Detection; Nurses; SQUAMOUS-CELL CARCINOMA; ACTINIC KERATOSIS; TRIAGE; PRACTITIONERS; MELANOMA;
D O I
10.1159/000369790
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The incidence and prevalence of skin cancer is rising. A detection model could support the (screening) process of diagnosing non-melanoma skin cancer. Methods: A questionnaire was developed containing potential actinic keratosis (AK) and basal cell carcinoma (BCC) characteristics. Three nurses diagnosed 204 patients with a lesion suspicious of skin (pre)malignancy and filled in the questionnaire. Logistic regression analyses generated prediction models for AK and BCC. Results: A prediction model containing nine characteristics correctly predicted the presence or absence of AK in 83.2% of the cases. BCC was predicted correctly in 91.4% of the cases by a model containing eight characteristics. The nurses correctly diagnosed AK in 88.3% and BCC in 90.9% of the cases. Conclusions: Detection or screening models for AK and BCC could be made with a limited number of variables. Nurses also diagnosed skin lesions correctly in a high percentage of cases. Further research is necessary to investigate the robustness of these findings, whether the percentage of correct diagnoses can be improved and how best to implement model-based prediction in the diagnostic process. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [31] Current therapy of non-melanoma skin cancer
    Schlaak, M.
    von Bartenwerffer, W.
    Mauch, C.
    HAUTARZT, 2011, 62 (06): : 430 - 435
  • [32] Photodynamic therapy for non-melanoma skin cancer
    Szeimies, RM
    Morton, CA
    Sidoroff, A
    Braathen, LR
    ACTA DERMATO-VENEREOLOGICA, 2005, 85 (06) : 483 - 490
  • [33] Update of cetuximab for non-melanoma skin cancer
    Wollina, Uwe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 271 - 276
  • [34] Neoadjuvant Approaches to Non-Melanoma Skin Cancer
    Wilde, David C.
    Glaun, Mica E.
    Wong, Michael K.
    Gross, Neil D.
    CANCERS, 2023, 15 (23)
  • [35] Evaluation of telomerase in non-melanoma skin cancer
    Boldrini, L
    Loggini, B
    Gisfredi, S
    Zucconi, Y
    Di Quirico, D
    Biondi, R
    Cervadoro, G
    Barachini, P
    Basolo, F
    Pingitore, R
    Fontanini, G
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (05) : 607 - 611
  • [36] Non-melanoma skin cancer in mouse and man
    Michael Schwarz
    Peter A. Münzel
    Albert Braeuning
    Archives of Toxicology, 2013, 87 : 783 - 798
  • [37] Palliative Radiotherapy for Non-melanoma Skin Cancer
    Barnes, E. A.
    Breen, D.
    Culleton, S.
    Zhang, L.
    Kamra, J.
    Tsao, M.
    Balogh, J.
    CLINICAL ONCOLOGY, 2010, 22 (10) : 844 - 849
  • [38] Human papillomaviruses in non-melanoma skin cancer
    de Villiers, EM
    Ruhland, A
    Sekaric, P
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (06) : 413 - 422
  • [39] Rhinophyma and non-melanoma skin cancer: An update
    Lazzeri, D.
    Agostini, T.
    Pantaloni, M.
    Spinelli, G.
    ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2012, 57 (02): : 183 - 184
  • [40] Histopathological evaluation of non-melanoma skin cancer
    Koyuncuer, Ali
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12